CIBC Private Wealth Group
PRCT icon

CIBC Private Wealth Group’s Procept Biorobotics PRCT Stock Holding History

CIBC Private Wealth Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$10.2K Buy
325
+86
+36% +$2.85K ﹤0.01% 2418
2025
Q3 		$8.53K Hold
239
– – ﹤0.01% 2444
2025
Q2 		$13.8K Sell
239
-16
-6% -$905 ﹤0.01% 2150
2025
Q1 		$12.4K Buy
+255
New +$17.4K ﹤0.01% 2167

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

CIBC Private Wealth Group's PRCT Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Procept Biorobotics (PRCT) stake by 36% in Q4 2025, buying an estimated $2.85K and bringing the position to 325 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

CIBC Private Wealth Group first reported a position in PRCT in Q1 2025 and has held it in 4 quarters since. The position peaked at $13.8K in Q2 2025. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • CIBC Private Wealth Group held 325 shares of Procept Biorobotics worth $10.2K as of Q4 2025.
  • CIBC Private Wealth Group bought 86 Procept Biorobotics shares in Q4 2025, an estimated $2.85K.
  • Procept Biorobotics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2418 holding.
  • CIBC Private Wealth Group first reported a position in Procept Biorobotics in Q1 2025 and has held it in 4 quarters since.
  • CIBC Private Wealth Group's Procept Biorobotics position peaked at $13.8K in Q2 2025.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.